Affimed N.V.
DelistedCIK 1608390fmd_115FFBQAMPDZSAQC393YAH8NVKManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Jun 30, 2024, 16 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 8 | 6 | 2 | 24 | 21 | 28 | 40 | 41 | 8 |
| Research and development | 22 | 30 | 21 | 35 | 44 | 50 | 81 | 99 | 95 |
| Selling, general and administrative | 8 | 8 | 8 | – | – | – | – | – | – |
| Operating income | (21) | (32) | (27) | (20) | (32) | (35) | (64) | (88) | (107) |
| Income before taxes | (20) | (32) | (30) | (19) | (32) | (41) | (58) | (86) | (106) |
| Income tax expense | 0 | (0) | (0) | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (20) | (32) | (30) | (19) | (32) | (41) | (58) | (86) | (106) |
| Net income | (20) | (32) | (30) | (19) | (32) | (41) | (58) | (86) | (106) |